Mineralocorticoid Receptor Modulators (Ligand)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMineralocorticoid Receptor Modulators (Ligand)
Drug Alias NameMR modulators (Ligand)MR modulators (Ligand/BMS)mineralocorticoid receptor modulators (Ligand/BMS)MR modulators (Ligand/Bristol-Myers Squibb)mineralocorticoid receptor modulators (Ligand/Bristol-Myers Squibb)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMineralocorticoid receptor modulators
TargetsMineralocorticoid receptor
Therapy Area/IndicationsHypertensionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLigand Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigand Pharmaceuticals IncBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsHypertensionHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A